Relative biological effectiveness enhancement of a 125I brachytherapy seed with characteristic x rays from its constitutive materials.
The isotopes used for permanent prostate implants, 125I and 103Pd, provide about equivalent tumor control. The purpose of this study is to investigate how characteristic x rays may be used to raise the relative biological effectiveness (RBE) of an iodine seed at short distances to increase the differential effect between tumor and healthy tissue. Within the theoretical framework of microdosimetry, the GEANT4 Monte Carlo simulation toolkit has been used to calculate the RBE of experimental seed designs in which shell and core dimensions and composition were varied independently. A new seed model was also simulated based on the best results obtained. The RBE could be enhanced by increasing the shell thickness and for the range considered, optimum results were obtained by using gradually lower atomic number elements. For a practical 50-60 microm shell, molybdenum is the material of choice. The core diameter has little influence on RBE, but maximum effectiveness is obtained with yttrium or zirconium. These results were put together to design a Mo-shell and Y-core seed for which the RBE enhancement was at least 5-7% (close to the source), which is higher than palladium. This enhanced RBE combined with the longer half-life of iodine could mean comparable tumor control and better protection to organs at risk than with current seeds. The RBE dependence on distance is an interesting feature that could benefit other applications such as ocular melanoma or coronary brachytherapy where a highly localized dose distribution is desired.
Taschereau
Richard
R
Centre Hospitalier Universitaire de Québec, Département de Radio-Oncologie, Canada. taschere@radonc17.ucsf.edu
Roy
René
R
Pouliot
Jean
J
D001918:Brachytherapy / Q000379:methods*; D006801:Humans; D007455:Iodine / Q000378:metabolism; D007457:Iodine Radioisotopes / Q000627:therapeutic use*; D007554:Isotopes; D008297:Male; D008545:Melanoma / Q000378:metabolism; D008962:Models, Theoretical; D009010:Monte Carlo Method; D011471:Prostatic Neoplasms / Q000532:radiotherapy; D011874:Radiometry; D012062:Relative Biological Effectiveness; D012984:Software; D014965:X-Rays
D007457:Iodine Radioisotopes; D007554:Isotopes; D007455:Iodine